Various Protein Receptor Functionality in Wound Healing.

IF 3.2 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Shahjad, Divyam Saxena, Yashika Garg, Arun Kumar, Sisir Nandi
{"title":"Various Protein Receptor Functionality in Wound Healing.","authors":"Shahjad, Divyam Saxena, Yashika Garg, Arun Kumar, Sisir Nandi","doi":"10.2174/0113816128479007260917054214","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The intricate biological process of wound healing encompasses several cellular activities, including proliferation, migration, angiogenesis, and immunological responses. Central to these actions are protein receptors that facilitate cell signaling pathways essential for tissue repair. Various receptor types such as integrins, toll-like receptors (TLRs), G-protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and RIPK3 govern these functions. This research aims to evaluate the current technology for measuring and modifying receptors, clarify the functions of different protein receptors in the wound healing cascade, and investigate theranostic strategies that utilize receptor signaling to improve wound healing and reduce complications.</p><p><strong>Methods: </strong>The investigators are reviewing receptors linked to wound healing. These receptors have been used for investigation, in vitro and in vivo modeling, and scientific developments for the identification and exploration of potential targets. To comprehend and control how receptors work through tissue repair, the present attempt uses crucial pharmacological inhibitors, ECM-based scaffolds, and receptor-targeted treatments.</p><p><strong>Results: </strong>Results have demonstrated the involvement of specific receptors, including NGF receptors, 5-HT1A receptors, RTKs, GPCRs, and RIPK3, in the process of wound healing. The phenomenon under consideration manifests in a variety of physiological processes, including the proliferation of blood vessels, the multiplication of cells, the movement of cells, and the modulation of the immune system. One approach involves the utilization of pharmaceutical agents that bind to the receptors.</p><p><strong>Discussion: </strong>An alternative approach involves the utilization of ECM scaffolds for the design of receptor inhibitors such as necrostatin-1 to target RIPK3. The process of developing pharmaceuticals derived from this research that can genuinely benefit human health is a challenging endeavor.</p><p><strong>Conclusion: </strong>These cells play a crucial role in facilitating proper wound healing. It is imperative to acquire a more profound understanding of the mechanisms underlying the function of protein receptors. This fundamental knowledge is essential for the development of effective tools that can measure and regulate these receptors. It is imperative to continue our research on protein receptors to elucidate the underlying mechanisms that result in their dysfunction. It is imperative to ensure the proper utilization of these novel pharmaceuticals in medical facilities to address both acute and chronic wound conditions.</p>","PeriodicalId":10845,"journal":{"name":"Current pharmaceutical design","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical design","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113816128479007260917054214","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The intricate biological process of wound healing encompasses several cellular activities, including proliferation, migration, angiogenesis, and immunological responses. Central to these actions are protein receptors that facilitate cell signaling pathways essential for tissue repair. Various receptor types such as integrins, toll-like receptors (TLRs), G-protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and RIPK3 govern these functions. This research aims to evaluate the current technology for measuring and modifying receptors, clarify the functions of different protein receptors in the wound healing cascade, and investigate theranostic strategies that utilize receptor signaling to improve wound healing and reduce complications.

Methods: The investigators are reviewing receptors linked to wound healing. These receptors have been used for investigation, in vitro and in vivo modeling, and scientific developments for the identification and exploration of potential targets. To comprehend and control how receptors work through tissue repair, the present attempt uses crucial pharmacological inhibitors, ECM-based scaffolds, and receptor-targeted treatments.

Results: Results have demonstrated the involvement of specific receptors, including NGF receptors, 5-HT1A receptors, RTKs, GPCRs, and RIPK3, in the process of wound healing. The phenomenon under consideration manifests in a variety of physiological processes, including the proliferation of blood vessels, the multiplication of cells, the movement of cells, and the modulation of the immune system. One approach involves the utilization of pharmaceutical agents that bind to the receptors.

Discussion: An alternative approach involves the utilization of ECM scaffolds for the design of receptor inhibitors such as necrostatin-1 to target RIPK3. The process of developing pharmaceuticals derived from this research that can genuinely benefit human health is a challenging endeavor.

Conclusion: These cells play a crucial role in facilitating proper wound healing. It is imperative to acquire a more profound understanding of the mechanisms underlying the function of protein receptors. This fundamental knowledge is essential for the development of effective tools that can measure and regulate these receptors. It is imperative to continue our research on protein receptors to elucidate the underlying mechanisms that result in their dysfunction. It is imperative to ensure the proper utilization of these novel pharmaceuticals in medical facilities to address both acute and chronic wound conditions.

各种蛋白质受体在伤口愈合中的功能。
创面愈合复杂的生物学过程包括多种细胞活动,包括增殖、迁移、血管生成和免疫反应。这些作用的核心是促进组织修复所必需的细胞信号通路的蛋白质受体。各种受体类型,如整合素、toll样受体(TLRs)、g蛋白偶联受体(gpcr)、受体酪氨酸激酶(rtk)和RIPK3控制着这些功能。本研究旨在评估目前的受体测量和修饰技术,阐明不同蛋白受体在伤口愈合级联中的功能,并探讨利用受体信号促进伤口愈合和减少并发症的治疗策略。方法:研究人员正在回顾与伤口愈合相关的受体。这些受体已被用于研究,体外和体内建模,以及识别和探索潜在靶点的科学发展。为了理解和控制受体如何在组织修复中起作用,目前的尝试使用了关键的药理学抑制剂、基于ecm的支架和受体靶向治疗。结果:研究结果表明,NGF受体、5-HT1A受体、rtk、gpcr、RIPK3等特异性受体参与了创面愈合过程。所考虑的现象表现在多种生理过程中,包括血管的增殖、细胞的增殖、细胞的运动和免疫系统的调节。一种方法是利用与受体结合的药物。讨论:另一种方法是利用ECM支架设计受体抑制剂,如坏死他汀-1靶向RIPK3。从这项研究中开发出真正有益于人类健康的药物的过程是一项具有挑战性的努力。结论:这些细胞在促进创面愈合中起重要作用。有必要对蛋白质受体的功能机制有更深刻的了解。这些基础知识对于开发测量和调节这些受体的有效工具至关重要。我们有必要继续对蛋白质受体的研究,以阐明导致其功能障碍的潜在机制。必须确保在医疗设施中正确利用这些新药,以解决急性和慢性伤口状况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
302
审稿时长
2 months
期刊介绍: Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field. Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书